VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 377 filers reported holding VANECK VECTORS ETF TR in Q3 2017. The put-call ratio across all filers is 1.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $249,000 | – | 11,280 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $25,094,000 | 16.41% |
| Windmill Hill Asset Management Ltd | 844,600 | $28,700,000 | 15.26% |
| Hollow Brook Wealth Management LLC | 671,454 | $22,816,000 | 14.18% |
| New Harbor Financial Group, LLC | 1,167,112 | $39,658,000 | 13.37% |
| Grand Central Investment Group | 423,252 | $14,382,000 | 12.82% |
| New Harbor Financial Group, LLC | 1,101,300 | $37,422,000 | 12.62% |
| Cadence Wealth Management LLC | 432,124 | $14,684,000 | 12.40% |
| Bienville Capital Management, LLC | 4,007,300 | $136,168,000 | 11.31% |
| ONE PLUS ONE WEALTH MANAGEMENT, LLC | 460,504 | $15,648,000 | 10.79% |
| Plaisance Capital LLC | 608,000 | $20,660,000 | 10.29% |